Richmond Fed Shows Sharp Drop in Manufacturing Gains in August
The Federal Reserve Bank of Richmond released its reading on manufacturing, showing a sharp drop in August.
All Work
Jon C. Ogg
Consumer Confidence Rockets Higher, but Timing Misses Latest Woes
The Conference Board has released a consumer confidence reading so strong you might wonder about its validity.
Markit Shows Positive Reading in Flash Services PMI
If investors want any good economic news, they are getting at least a bit of it from the Markit Flash U.S. Services PMI reading for August.
Oppenheimer’s 7 Bull Market Leaders to Buy After the Sell-Off
Oppenheimer has issued a call for investors to buy seven bull market leaders, including Apple, Amazon and Bank of America.
Top Analyst Upgrades and Downgrades: Apple, BofA, Canadian Solar, Garmin, Regions Financial, Euronav and Many More
Tuesday's top analyst upgrades, downgrades and initiations include Apple, Bank of America, Canadian Solar, Garmin, Regions Financial and Euronav.
How the Markets See China Rate Cut and Bank Reserve Requirement Cut
China has decided to respond to the major market concerns out of Shanghai. The move has bolstered exchange levels, although some of the moves may feel a bit muted compared to more recent actions.
Mirna Therapeutics Files for IPO
Mirna Therapeutics has filed with the Securities and Exchange Commission (SEC) to conduct an initial public offering (IPO).
4 Speculative Chinese Stocks That Tanked Far Worse Than Shanghai Did Monday
Monday's global equity market trading day was nothing short of having a sudden irritable bowel syndrome attack.
2 Positive Health Care REIT Views
Physicians Realty Trust and Health Care REIT were both given positive analyst views by the analyst team at Canaccord Genuity.
Is Taubman Centers Finally Cheap Enough?
Taubman Centers may be down with the broader market on Monday, but the analyst research team at Oppenheimer decided to raise its rating.
Have Search Results Become Static?
The latest data issued from comScore showed its monthly comScore qSearch results for the U.S. desktop search marketplace in July.
FDA Grants Expanded Use of Promacta for Novartis
ThinkstockNovartis AG (NYSE: NVS) is one of the few companies with good news on a major market sell-off. Unfortunately, it is not big enough news to be moving the shares. The Swiss drug giant…
How Relevant is Vital Therapies After Its Selloff?
ThinkstockVital Therapies Inc. (NASDAQ: VTL) was last seen trading down 80% at $3.41 (versus $17.68 close) after it said that its Phase 3 trial in AILD (alcohol-induced liver decompensation) failed. Vital Therapies was downgraded…
Will Earnings Suffice at Children’s Place?
ThinkstockThe Children’s Place, Inc. (NASDAQ: PLCE) is among the retailers expected to report earnings this week. Its earnings report is due Tuesday morning, and some investors are wondering whether the children’s destination retail store…
Piper Jaffray Upgraded A&F Ahead of Earnings
Abercrombie & Fitch Co. (NYSE: ANF) bucked much of the selling pressure on Monday. Just hours ahead of its earnings report this Tuesday, Piper Jaffray raised its official analyst rating to Outperform from Neutral.…
Pfizer Gets Approval For Hospira Acquisition
ThinkstockAt a time when there is pressure on how large US companies are making domestic or overseas acquisitions are coming under more scrutiny, Pfizer Inc. (NYSE:PFE) announced on Monday that the Federal Trade Commission…
Why Analysts Will Slash Price Targets Even If They Keep Their Buy Ratings
The question is whether we are starting to find a bottom or if the market is heading even lower. Do investors try to get greedy or do they run for the hills?
Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead
24/7 Wall St. has wanted to check on the major stocks in the market with an eagle-eye view of where investors may start to buy stocks, as long as they do not feel this…
During Massive Sell-Offs, Triple-Leverage ETFs Look Nuts With NYSE Circuit Breakers
During market sell-offs, market crashes and periods of major uncertainty, triple-leverage exchange traded funds become the most battered of all.
Bonds Versus Stocks in a Sell-Off, via ETFs
Any time there is a major sell-off in stock, bonds usually are the beneficiary. The problem this time around is that interest rates are already so low.